Auna S.A. (AUNA)vsNovartis AG ADR (NVS)
AUNA
Auna S.A.
$4.41
-2.00%
HEALTHCARE · Cap: $333.25M
NVS
Novartis AG ADR
$148.38
-0.96%
HEALTHCARE · Cap: $273.77B
Smart Verdict
WallStSmart Research — data-driven comparison
Novartis AG ADR generates 1151% more annual revenue ($56.58B vs $4.52B). NVS leads profitability with a 23.9% profit margin vs 1.5%. AUNA trades at a lower P/E of 16.7x. NVS earns a higher WallStSmart Score of 49/100 (D+).
AUNA
Hold49
out of 100
Grade: D+
NVS
Hold49
out of 100
Grade: D+
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for AUNA.
Margin of Safety
-62.1%
Fair Value
$91.39
Current Price
$148.38
$56.99 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Attractively priced relative to earnings
Mega-cap, among the largest globally
Every $100 of equity generates 35 in profit
Strong operational efficiency at 30.5%
Keeps 24 of every $100 in revenue as profit
Generating 2.9B in free cash flow
Areas to Watch
Smaller company, higher risk/reward
ROE of 3.9% — below average capital efficiency
1.5% margin — thin
Weak financial health signals
Grey zone — moderate risk
Elevated debt levels
Expensive relative to growth rate
Revenue declined 0.7%
Comparative Analysis Report
WallStSmart ResearchBull Case : AUNA
The strongest argument for AUNA centers on Price/Book, P/E Ratio. Revenue growth of 13.0% demonstrates continued momentum.
Bull Case : NVS
The strongest argument for NVS centers on Market Cap, Return on Equity, Operating Margin. Profitability is solid with margins at 23.9% and operating margin at 30.5%.
Bear Case : AUNA
The primary concerns for AUNA are Market Cap, Return on Equity, Profit Margin. Debt-to-equity of 2.19 is elevated, increasing financial risk. Thin 1.5% margins leave little buffer for downturns.
Bear Case : NVS
The primary concerns for NVS are Altman Z-Score, Debt/Equity, PEG Ratio.
Key Dynamics to Monitor
AUNA profiles as a value stock while NVS is a declining play — different risk/reward profiles.
AUNA carries more volatility with a beta of 1.03 — expect wider price swings.
AUNA is growing revenue faster at 13.0% — sustainability is the question.
NVS generates stronger free cash flow (2.9B), providing more financial flexibility.
Bottom Line
AUNA scores higher overall (49/100 vs 49/100) and 13.0% revenue growth. Both earn "Hold" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Auna S.A.
HEALTHCARE · MEDICAL CARE FACILITIES · USA
Auna S.A. is a leading telecommunications and digital services provider in Latin America, offering a diverse range of integrated solutions that enhance connectivity for both residential and business clients. The company's extensive portfolio includes high-speed internet, television, and mobile services, underscoring its commitment to innovation and superior customer experience. Auna's robust infrastructure and strategic positioning enable it to capitalize on the increasing demand for advanced telecommunications solutions, making it an attractive investment opportunity for institutional investors seeking exposure to the region's expanding digital economy.
Visit Website →Novartis AG ADR
HEALTHCARE · DRUG MANUFACTURERS - GENERAL · USA
Novartis AG researches, develops, manufactures and markets medical devices worldwide. The company is headquartered in Basel, Switzerland.
Visit Website →Compare with Other MEDICAL CARE FACILITIES Stocks
Want to dig deeper into these stocks?